The Centers for Medicare & Medicaid Services late yesterday issued a proposed rule for the inpatient rehabilitation facility prospective payment system for fiscal year 2023 that would increase payments by 2.8% ($170 million) relative to FY 2021 after a 0.4-percentage-point productivity adjustment and a 0.8-percentage-point cut for high-cost outlier payments.
 
CMS also proposes to cap wage index decreases at 5% to mitigate instability in IRF PPS payments; and seeks comments on potential changes to the IRF transfer payment policy, facility-level adjustment factors and IRF teaching status adjustment policy. 
 
In addition, CMS proposes to require IRFs to collect quality data on all patients, regardless of payer, beginning in October 2023. The agency estimates that the additional reporting burden will cost IRFs over $31 million per year (an average of nearly $29,000 per IRF). CMS does not propose any other changes to the IRF Quality Reporting Program, but it does solicit feedback on the potential future use of an electronic health record-informed quality measure as well as frameworks to address disparities in outcomes.

CMS will accept comments on the rule until 5 p.m. on May 31.

Perspective
Public
Approximately 35 million Americans are enrolled in Medicare Advantage plans in 2026, and that number is expected to grow to about 45 million MA enrollees by…
Headline
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns…
Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…